Intravenous nizatidine kinetics and acid suppression

Publisher Website
Google Scholar
Abstract
The effectiveness of i.v. nizatidine in suppressing gastric acid secretion was evaluated by different methods of inducing secretion in 2 single-blind studies. In study 1, 7 subjects were given single, 20 min i.v. infusions of nizatidine (6.25, 25, 75, 150 or 250 mg) before modified sham feeding (MSF). Gastric acid suppression after nizatidine was contrasted with that after placebo and MSF. All doses of nizatidine reduced secretion; the 150 and 250 mg doses of nizatidine suppressed secretion for at least 2.5 h. In study 2, 8 subjects received one 5 min i.v. infusion of placebo, cimetidine (300 mg) or nizatidine (25, 50, 100 or 250 mg) weekly for 6 wk. Secretion was induced by infusing pentagastrin (2 .mu.g/kg per h) 45 min before the study drug was dosed and for 3.5 h thereafter. All doses of nizatidine reduced gastric acid, chiefly by decreasing volume. Nizatidine induced a clear dose-response effect; nizatidine (100 mg) and cimetidine (300 mg) had approximately equal suppressive effects. Nizatidine (100 mg) and cimetidine (300 mg) reduced acid output by 62% and 63% and reduced volume of secretion by 48% and 51% over the 3.5 h period. Gastric acid suppression and plasma nizatidine concentrations were directly related. Nizatidine kinetics were linear and proportional to dose. The t1/2 [half time] was 1.3 h (range 0.7-2.1 h), the volume of distribution was 1.2 .+-. 0.5 l/kg, and clearance was 0.6 .+-. 0.2 l/kg per h. Laboratory abnormalities and side effects were minor in both studies.